A survey was carried out in 1986 for the occurrence of aflatoxin B1 in peanut butters (129 samples) obtained from specialist Health Food outlets. The results showed that 6.2% of the samples exceeded 10 micrograms/kg of aflatoxin, 8% contained between 2.5 and 10 micrograms/kg, and in the remainder (86%) aflatoxin could not be detected at a limit of 2.5 micrograms/kg. These results show a lower contamination by aflatoxin than found in these products in previous surveys (1982-1984). An aflatoxin B1-specific enzyme-linked immunosorbent assay (ELISA) was employed for the first time in these analyses; and to make an assessment of its performance positive aflatoxin results, together with a random selection of those below the ELISA limit of detection, were additionally analysed by conventional extraction and clean-up followed by HPLC. The ELISA technique offered a significant improvement in speed of analysis over conventional approaches, enabling a six-fold increase in sample throughput compared to that required for conventional analysis, together with other advantages.
No takes yet. Share an insight, caveat, or question.
Mortimer et al. (1988) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: